Portfolio Strategies (Washington)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Portfolio Strategies (Washington)'s BMY Position: Q4 2017 in Review
Portfolio Strategies (Washington) held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 200 shares worth $12K. The position accounts for 0.02% of the portfolio, ranked #50.
Portfolio Strategies (Washington) first reported a position in BMY in Q4 2016 and has held it in 5 quarters since. The position peaked at $13K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Portfolio Strategies (Washington) held 200 shares of Bristol-Myers Squibb worth $12K as of Q4 2017.
- Portfolio Strategies (Washington) left its Bristol-Myers Squibb share count unchanged in Q4 2017.
- Bristol-Myers Squibb made up 0.02% of Portfolio Strategies (Washington)'s portfolio in Q4 2017, its #50 holding.
- Portfolio Strategies (Washington) first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 5 quarters since.
- Portfolio Strategies (Washington)'s Bristol-Myers Squibb position peaked at $13K in Q3 2017.
- 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Portfolio Strategies (Washington)'s 13F filing for Q4 2017, filed 13 Feb 2018.